Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blood Coagulation Disorders | Discovery | - | 12 Sep 2024 | |
Cardiovascular Diseases | Discovery | - | 12 Sep 2024 | |
Chronic Kidney Diseases | Discovery | - | 12 Sep 2024 | |
Digestive System Disorders | Discovery | - | 12 Sep 2024 | |
Endocrinology and Metabolic Disease | Discovery | - | 12 Sep 2024 | |
Nervous System Diseases | Discovery | - | 12 Sep 2024 |